Neuphoria Therapeutics
$3.77
15
+$0.01+0.27% Friday 19:58
-$0.03-0.7%Friday 22:31After hours
Statistics
Day High
3.77
Day Low
3.77
52W High
21.4
52W Low
3.19
Volume
155
Avg. Volume
-
Mkt Cap
20.38M
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Earnings
2DecExpected
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Q1 2026
Next
Next
-4.41
-3.13
-1.84
-0.56
Expected EPS
-1.58
Actual EPS
N/A
People Also Follow
This list is based on the watchlists of people on Stock Events who follow NEUP. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
Neuphoria Therapeutics Inc is a clinical-stage biotechnology company dedicated to developing therapies that address the complex needs of individuals affected by neuropsychiatric disorders. The company is advancing its drug candidate, BNC 210, an oral, proprietary, selective negative allosteric modulator of the Alpha7 nicotinic acetylcholine receptor, for the acute treatment of social anxiety disorder and for chronic treatment of post-traumatic stress disorder. The Company operates through a single operating and reportable segment focused on the discovery and development of allosteric ion channel modulators designed to transform the lives of patients suffering from serious central nervous system (CNS) disorders with high unmet medical need.
Show more...
CEO
Spyridon Papapetropoulos
Employees
8
Country
United States
ISIN
US64136E1029
Listings
0 Comments
Share your thoughts
FAQ
What is Neuphoria Therapeutics stock price today?▼
The current price of NEUP is $3.77 USD — it has increased by +0.27% in the past 24 hours. Watch Neuphoria Therapeutics stock price performance more closely on the chart.
What is Neuphoria Therapeutics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Neuphoria Therapeutics stocks are traded under the ticker NEUP.
Is Neuphoria Therapeutics stock price growing?▼
NEUP stock has risen by +0.27% compared to the previous week, the month change is a -4.56% fall, over the last year Neuphoria Therapeutics has showed a -68.29% decrease.
What is Neuphoria Therapeutics market cap?▼
Today Neuphoria Therapeutics has the market capitalization of 20.38M
When is the next Neuphoria Therapeutics earnings date?▼
Neuphoria Therapeutics is going to release the next earnings report on December 02, 2026.
How many employees does Neuphoria Therapeutics have?▼
As of September 05, 2026, the company has 8 employees.
In which sector is Neuphoria Therapeutics located?▼
Neuphoria Therapeutics operates in the Health & Wellness sector.
When did Neuphoria Therapeutics complete a stock split?▼
Neuphoria Therapeutics has not had any recent stock splits.
Where is Neuphoria Therapeutics headquartered?▼
Neuphoria Therapeutics is headquartered in BURLINGTON, United States.